Pinnacle Biologics, Inc. is a biotechnology and pharmaceutical company based in the United States, specializing in revitalizing healthcare therapies. Since its founding in 2007, the company has been dedicated to promoting, developing, and managing innovative approaches to the global commercialization of products in the oncology and specialty areas. Pinnacle Biologics' mission is to maximize patient benefit by ensuring that pharmaceuticals and healthcare devices reach their highest potential.
The company received a $1.50M Venture Round investment on 30 December 2011. The details of the investors for this round are not available at the moment.
With a focus on oncology and specialty healthcare, Pinnacle Biologics aims to make significant contributions to the biotechnology and pharmaceutical industries, leveraging its unique experience and approach. To learn more about the company, visit their website at www.pinnaclebiologics.com.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | $1.50M | - | 30 Dec 2011 |
No recent news or press coverage available for Pinnacle Biologics, Inc..
We care about your data, and we'd love to use cookies make your experience better.
